GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Think Research Corp (TSXV:THNK) » Definitions » YoY EBITDA Growth

Think Research (TSXV:THNK) YoY EBITDA Growth : 97.06% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Think Research YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Think Research's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 97.06%.

Think Research's EBITDA per Share for the three months ended in Sep. 2023 was C$-0.00.


Think Research YoY EBITDA Growth Historical Data

The historical data trend for Think Research's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Think Research YoY EBITDA Growth Chart

Think Research Annual Data
Trend Sep20 Dec21 Dec22
YoY EBITDA Growth
- -138.04 64.38

Think Research Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.22 83.78 106.25 124.24 97.06

Think Research YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Think Research's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.156--0.438)/ | -0.438 |
=64.38 %

Think Research's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.001--0.034)/ | -0.034 |
=97.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Think Research YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Think Research's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Think Research (TSXV:THNK) Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
Think Research Corp and its subsidiaries are a healthcare technology company digitalizing the delivery of knowledge to facilitate better healthcare outcomes. The company gathers, develops, and delivers a knowledge-based Software-as-a-Service solution globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and/or governments. Its cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care, including primary physician care, acute care hospitals and surgical suites as well as community and senior care.

Think Research (TSXV:THNK) Headlines

No Headlines